https://www.avient.com/resources/safety-data-sheets?page=3806
FDM 166906 FT POM SL MASTERBATCH
YELLOW TP PET 3
https://www.avient.com/resources/safety-data-sheets?page=2794
43427 YE PA MASTERBATCH
DW SEXY TURQ PET V2
https://www.avient.com/resources/safety-data-sheets?page=2845
183169 OR SAN MASTERBATCH
NATURAL PET
https://www.avient.com/resources/safety-data-sheets?page=2624
SKY BLUE 283 PET
FDM 94751 GY LLDPE MASTERBATCH
https://www.avient.com/resources/safety-data-sheets?page=7141
TRANS BLUE 662C PET F
408149 YE MABS MASTERBATCH
https://www.avient.com/resources/safety-data-sheets?page=737
34170 RD EVA MASTERBATCH
INFUSED GREEN PET II
https://www.avient.com/resources/safety-data-sheets?page=6603
33916 WT PP MASTERBATCH
PET TRANS GREEN
https://www.avient.com/investor-center/news/avient-provides-third-quarter-2020-performance-update
Increased Clariant Masterbatch cost synergy estimate to $75 million from preliminary estimate of $60 million
NYSE: AVNT), a leading provider of specialized and sustainable material solutions, provided third quarter financial performance expectations today as well as updated synergy estimates related to the Clariant Masterbatch acquisition.
added, "We are also benefitting from the acquisition of the Clariant Masterbatch business, which has been immediately accretive to adjusted EPS."
https://www.avient.com/news/archives?page=32
New Rejoin™ PCR Masterbatch Makes 100 Percent PCR a Reality for Polyolefin Packaging
CLEVELAND – March 12, 2021 – Avient today announced the launch of Rejoin™ PCR Masterbatch for polyolefin packaging applications.
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
$0.30
$0.52
2019 PF 2020
Q4 2020 ORGANIC PERFORMANCE
3
Sales
$922
$997
2019 PF 2020
+8%
Adjusted
Operating
Income
Adjusted
EPS
$58
$80
2019 PF 2020
+38%
+73%
• Record 4th quarter sales, adjusted
operating income and adjusted EPS
performance
• All segments delivered year-over-year
sales and operating income growth, led
by consumer and healthcare end markets
• Clariant Masterbatch integration synergy
capture ahead of schedule: $5 million
realized in 2020
($ in millions except EPS)
(1)
(1)
(1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Q4 2020 SEGMENT PERFORMANCE
4
Sales Operating Income
$100 $100 $100
$922
$100 $100 $100
$997
Distribution CAI SEM Total
2019 2020
$178
$272
$490
$191
$305
$526
SEM Distribution CAI
2019PF 2020
+8%
+7%
+7%
+12%
$5 $5 $5
$58
$5 $5 $5
$80
Avient CAI SEM Total
2019 PF 2020
$17 $19
$40
$18
$30
$58
Distribution SEM CAI
2019PF 2020
+38%
+45%
+58%
+6%
(3) (3)
($ in millions)
(1) (2)
(1) Total company sales include intercompany sales eliminations
(2) Total company reflects adjusted operating income and includes corporate costs
(3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
2020 HIGHLIGHTS
5
• Completed transformational Clariant Masterbatch acquisition and created new
brand name Avient
• Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier
during the pandemic and due to growth in demand for consumer applications
• Specialty Engineered Materials delivered record operating income on gains from
composites
• Achieved record free cash flow, increased dividend for 10th year in a row and
delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA
• Culture is everything: Certified as a Great Place to Work®
$133
$150
2019PF 2020PF
10%
23%8%
21%
4%
15%
2006 2020PF
Healthcare
Consumer
Packaging
Avient Portfolio Transformation
22%
59%
CLARIANT MASTERBATCH:
TRANSFORMATIONAL ACQUISITION
6
Clariant MB EBITDA Growth
Purchase Price Multiple
10.8
9.6
6.5
2019PF 2020PF 2020PF w/ Full
Synergies
x
x
x
• Acquisition of Clariant Masterbatch
significantly expands presence in
healthcare, packaging and consumer end
markets
• Strength of portfolio – 13% EBITDA growth
as an essential supplier in COVID response
and recovery
• Acquisition completed on July 1, 2020 for
$1.4 billion.
We will deliver for our stakeholders through multiple value creation levers—many of
which are unique to Avient:
o Demand for sustainable solutions, healthcare, and composites, together with Clariant
Masterbatch revenue synergies, that will drive 2021 revenue growth of 8% and long-term growth
in excess of GDP
o Clariant Masterbatch cost synergy capture will result in significant near-term benefit
In addition, we remain committed to increasing annual dividends in line with earnings growth and
opportunistically buying back shares, all while remaining modestly levered.
Avient acquired the Clariant Masterbatch business (CMB) on July 1, 2020 (the “Acquisition Date”).